Table 3.
AIM Study (n = 64) | Comparator Study9 (n = 153) | |||
---|---|---|---|---|
|
|
|||
Patient % | Patient % | |||
|
|
|||
EPIC Item for Bowel Function | Pretreatment | Post-treatment (2 mo) | Pretreatment | Post-treatment (2 mo) |
Urgency | 9 | 8 | 3 | 22 |
Frequency | 3 | 8 | 2 | 22 |
Fecal incontinence | 3 | 3 | 1 | 7 |
Bloody stools | 3 | 2 | 2 | 5 |
Rectal pain | 6 | 3 | 5 | 9 |
Overall bowel problem | 9 | 6 | 4 | 20 |
EPIC, Expanded Prostate Cancer Index Composite; AIM, Assessing the Impact of Margin Reduction.